IDO1, a therapeutic target in depression, metabolizes tryptophan to KYN and is upregulated during pro-inflammatory states induced by several cytokines (IL-1β, IL-6, IFN-α, TNF-α) [51, 52]. The gene discussed is IL1B; the disease is major depressive disorder.